Skip to main
PEPG

PepGen Inc (PEPG) Stock Forecast & Price Target

PepGen Inc (PEPG) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PepGen Inc. is poised for significant growth due to its advanced Enhanced Delivery Oligonucleotide platform, which has demonstrated superior tissue penetration and cellular uptake in preclinical studies. The company's lead asset, PGN-EDO51, has shown a remarkable 53.7% splicing correction, surpassing competitors and indicating strong potential for measurable improvements in muscle performance in upcoming clinical trials. As shares trade around ~$4, the analysis suggests meaningful upside potential contingent on positive multi-dose data outcomes, highlighting optimism surrounding the company's innovative pipeline and efficacy results.

Bears say

The financial outlook for PepGen Inc. appears negative due to a recent model update indicating a decrease in the projected stock target by $1 to $8 per share. The company's positioning, despite delivering promising data for its DM1 treatment, reflects a substantial market cap discount compared to competitors like Dyne, which raises concerns regarding execution and the ability to meet stakeholder expectations. Additionally, potential challenges in accessing capital markets could hinder development efforts, leading to possible delays or termination of key projects, further negatively impacting investor sentiment.

PepGen Inc (PEPG) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PepGen Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PepGen Inc (PEPG) Forecast

Analysts have given PepGen Inc (PEPG) a Strong Buy based on their latest research and market trends.

According to 4 analysts, PepGen Inc (PEPG) has a Strong Buy consensus rating as of Jan 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $11.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $11.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PepGen Inc (PEPG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.